Skip to search formSkip to main contentSkip to account menu

fluorodopa F 18

Known as: Fluorine F 18 Fluorodopa, fluorodopa F 18, (18)F-labeled cpd, 3,4-dihydroxy-6-fluorophenylalanine 
The amino acid analog fluorodopa (FDOPA) labeled with fluorine F 18, a positron-emitting isotope, with potential tumor tracer property. Fluorine F 18… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

DopaLevodopa
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Pancreatic Endocrine Tumors
Pancreatic endocrine tumors have been steadily growing in incidence and prevalence during the last two decades, showing an… 
Review
2010
Review
2010
Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET.
Highly Cited
2008
Highly Cited
2008
The role of 18F‐FDOPA and 18F‐FDG–PET in the management of malignant and multifocal phaeochromocytomas
Background  18F‐DOPA has emerged as a promising tool in the localization of chromaffin‐tissue‐derived tumours. Interestingly… 
Highly Cited
2001
Highly Cited
2001
A Reversible Tracer Analysis Approach to the Study of Effective Dopamine Turnover
Changes in dopamine turnover resulting from disease states such as Parkinson's disease may be reflected in corresponding changes… 
Highly Cited
1997
Highly Cited
1997
Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA.
UNLABELLED Fluorinated m-tyrosine analogs were evaluated as PET imaging agents and compared with 6-fluoroDOPA in the… 
Highly Cited
1994
Highly Cited
1994
Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects.
UNLABELLED Fluorine-18-6-fluorodopa (FD) positron emission tomography (PET) is established for measuring nigrostriatal… 
Highly Cited
1994
Highly Cited
1994
Parkinsonism induced by solvent abuse
We report the first description of a patient with parkinsonism induced by solvent abuse. Our patient developed parkinsonism… 
1992
1992
3‐O‐methyldopa administration does not alter fluorodopa transport into the brain
To determine if 3‐O‐methyldopa (3OMd) significantly inhibits the transport of 6‐{18F} fluorodopa (6‐FD) into the brain at the… 
Highly Cited
1990
Highly Cited
1990
Blood—Brain Transfer and Metabolism of 6-[18F]Fluoro-L-DOPA in Rat
In a study designed to reveal the rates of blood–brain transfer and decarboxylation of fluoro-L-3,4-dihydroxyphenylalanine (FDOPA… 
Highly Cited
1978
Highly Cited
1978
[18F]fluoro-dopa, an analogue of dopa, and its use in direct external measurements of storage, degradation, and turnover of intracerebral dopamine.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)